TickerFacts.

A business in context

MED research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-26 · 0001213900-26-094862

  2. 4 · Ownership change

    Report date 2026-08-24 · 0001213900-26-093824

  3. 4 · Ownership change

    Report date 2026-08-19 · 0001213900-26-092479

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-051928

  5. 8-K · Current report

    Report date 2026-08-03 · 0001628280-26-051845 · Items 2.02,9.01

  6. 8-K · Current report

    Report date 2026-07-17 · 0001628280-26-048574 · Items 7.01,9.01

  7. 8-K · Current report

    Report date 2026-05-29 · 0001628280-26-039293 · Items 5.02,9.01

  8. 4 · Ownership change

    Report date 2026-05-26 · 0001628280-26-038983

  9. 4 · Ownership change

    Report date 2026-05-26 · 0001628280-26-038981

  10. 4 · Ownership change

    Report date 2026-05-26 · 0001628280-26-038978

  11. 4 · Ownership change

    Report date 2026-05-26 · 0001628280-26-038976

  12. 4 · Ownership change

    Report date 2026-05-26 · 0001628280-26-038974

  13. 8-K · Current report

    Report date 2026-05-19 · 0001628280-26-038109 · Items 5.02,5.07,7.01,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-029898

  15. 8-K · Current report

    Report date 2026-05-04 · 0001628280-26-029812 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-05-19 · 0001628280-26-023890

  17. 8-K · Current report

    Report date 2026-03-19 · 0001628280-26-019983 · Items 1.01,5.02,7.01,9.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-008656

  19. 8-K · Current report

    Report date 2026-02-17 · 0001628280-26-008641 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2025-12-30 · 0001628280-26-000235 · Items 5.02,9.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-048332

  22. 8-K · Current report

    Report date 2025-11-03 · 0001628280-25-048251 · Items 2.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000910329-25-000016

  24. 8-K · Current report

    Report date 2025-08-04 · 0000910329-25-000015 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-06-18 · 0001628280-25-032457 · Items 5.02,5.07,9.01

  26. DEF 14A · Proxy statement

    Report date 2025-06-18 · 0001628280-25-020673

  27. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-020341

  28. 8-K · Current report

    Report date 2025-04-28 · 0001628280-25-020336 · Items 2.02,9.01

  29. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-006094

  30. 8-K · Current report

    Report date 2025-02-18 · 0001628280-25-006036 · Items 2.02,9.01

  31. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001628280-24-045040

  32. 8-K · Current report

    Report date 2024-10-30 · 0001628280-24-045012 · Items 1.02,2.02

  33. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001628280-24-034791

  34. 8-K · Current report

    Report date 2024-08-05 · 0001628280-24-034743 · Items 2.02,9.01

  35. SC 13G/A · Ownership disclosure

    0001104659-24-078888

  36. SC 13G/A · Ownership disclosure

    0001086364-24-008158

  37. SC 13G · Ownership disclosure

    0001273087-24-000081

  38. 8-K · Current report

    Report date 2024-06-19 · 0001628280-24-029369 · Items 5.02,5.07,9.01

  39. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001628280-24-019046

  40. 8-K · Current report

    Report date 2024-04-29 · 0001628280-24-019030 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 2 transaction rows2PSale: 0 transaction rows0SGrant / award: 8 transaction rows8AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

10 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-26
2026-05-28
Rose Jeffrey MatthewA · Grant / award
Acquired
Common Stock6739.00.0
2026-05-26
2026-05-28
Rose Jeffrey MatthewA · Grant / award
Acquired
Common Stock11680.00.0
2026-05-26
2026-05-28
Kiai ParsaA · Grant / award
Acquired
Common Stock7637.00.0
2026-05-26
2026-05-28
Kiai ParsaA · Grant / award
Acquired
Common Stock11680.00.0
2026-05-26
2026-05-28
Thomas Andrea BA · Grant / award
Acquired
Common Stock11680.00.0
2026-05-26
2026-05-28
SCHLACKMAN SCOTTA · Grant / award
Acquired
Common Stock11680.00.0
2026-05-26
2026-05-28
Geary Elizabeth A.A · Grant / award
Acquired
Common Stock11680.00.0
2026-05-26
2026-05-28
Xian MingA · Grant / award
Acquired
Restricted Stock Units (cash settled)
Derivative security
11680.00.0
2026-05-11
2026-05-12
SCHLACKMAN SCOTTP · Purchase
Acquired
Common Stock2500.012.53
2026-05-08
2026-05-12
SCHLACKMAN SCOTTP · Purchase
Acquired
Common Stock2500.012.65

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000910329MEDIFAST INC
OPTAVIA, LLC

Showing 1 of 1 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
5299000YHQJ21T5KKI80
GLEIF legal name
Medifast, Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2021-07-13T06:53:08Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Medifast · alias · wikidata
  • OPTAVIA, LLC · subsidiary · wikidata
  • tsfl, optavia,take shape for life · subsidiary · wikidata
  • HEALTHRITE INC · former SEC name · 1996-08-14 to 2001-01-09
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$602.46M$641.30M
2023-12-31$1.07B$1.17B
2022-12-31$1.60B$1.82B
2021-12-31$1.53B$1.88B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗